ES409464A1 - Procedimiento para la produccion de cepas de virus. - Google Patents
Procedimiento para la produccion de cepas de virus.Info
- Publication number
- ES409464A1 ES409464A1 ES409464A ES409464A ES409464A1 ES 409464 A1 ES409464 A1 ES 409464A1 ES 409464 A ES409464 A ES 409464A ES 409464 A ES409464 A ES 409464A ES 409464 A1 ES409464 A1 ES 409464A1
- Authority
- ES
- Spain
- Prior art keywords
- virus
- checked
- specific
- attenuated viruses
- interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 230000002238 attenuated effect Effects 0.000 title 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000007246 mechanism Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000037125 natural defense Effects 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2161344A DE2161344C3 (de) | 1971-12-10 | 1971-12-10 | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES409464A1 true ES409464A1 (es) | 1976-03-16 |
Family
ID=5827622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES409464A Expired ES409464A1 (es) | 1971-12-10 | 1972-12-09 | Procedimiento para la produccion de cepas de virus. |
Country Status (21)
| Country | Link |
|---|---|
| JP (2) | JPS5924137B2 (es) |
| AR (1) | AR204075A1 (es) |
| AT (1) | AT326817B (es) |
| AU (1) | AU473209B2 (es) |
| BE (1) | BE792484A (es) |
| BG (1) | BG21417A3 (es) |
| CA (1) | CA988848A (es) |
| CH (1) | CH577558A5 (es) |
| CS (1) | CS189587B2 (es) |
| DD (1) | DD108115A5 (es) |
| DE (1) | DE2161344C3 (es) |
| DK (1) | DK143201C (es) |
| ES (1) | ES409464A1 (es) |
| FR (1) | FR2162637B1 (es) |
| GB (1) | GB1356076A (es) |
| HU (1) | HU167086B (es) |
| IE (1) | IE36995B1 (es) |
| NL (1) | NL178014C (es) |
| PH (1) | PH12597A (es) |
| SE (1) | SE8400283L (es) |
| ZA (1) | ZA728709B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
-
0
- BE BE792484D patent/BE792484A/xx not_active IP Right Cessation
-
1971
- 1971-12-10 DE DE2161344A patent/DE2161344C3/de not_active Expired
-
1972
- 1972-01-01 AR AR245553A patent/AR204075A1/es active
- 1972-12-01 PH PH14135A patent/PH12597A/en unknown
- 1972-12-05 JP JP47121264A patent/JPS5924137B2/ja not_active Expired
- 1972-12-05 JP JP47121265A patent/JPS6011013B2/ja not_active Expired
- 1972-12-06 BG BG022052A patent/BG21417A3/xx unknown
- 1972-12-07 CS CS728391A patent/CS189587B2/cs unknown
- 1972-12-07 AT AT1041972A patent/AT326817B/de not_active IP Right Cessation
- 1972-12-07 NL NLAANVRAGE7216628,A patent/NL178014C/xx not_active IP Right Cessation
- 1972-12-08 CH CH1791372A patent/CH577558A5/xx not_active IP Right Cessation
- 1972-12-08 GB GB5672372A patent/GB1356076A/en not_active Expired
- 1972-12-08 HU HUBA2833A patent/HU167086B/hu unknown
- 1972-12-08 CA CA158,535A patent/CA988848A/en not_active Expired
- 1972-12-08 DD DD167455A patent/DD108115A5/xx unknown
- 1972-12-08 DK DK615472A patent/DK143201C/da not_active IP Right Cessation
- 1972-12-08 ZA ZA728709A patent/ZA728709B/xx unknown
- 1972-12-08 IE IE1716/72A patent/IE36995B1/xx unknown
- 1972-12-08 FR FR7243868A patent/FR2162637B1/fr not_active Expired
- 1972-12-09 ES ES409464A patent/ES409464A1/es not_active Expired
- 1972-12-11 AU AU49920/72A patent/AU473209B2/en not_active Expired
-
1984
- 1984-01-20 SE SE8400283A patent/SE8400283L/sv not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS4862919A (es) | 1973-09-01 |
| IE36995L (en) | 1973-06-10 |
| GB1356076A (en) | 1974-06-12 |
| ZA728709B (en) | 1973-08-29 |
| JPS4862912A (es) | 1973-09-01 |
| DD108115A5 (es) | 1974-09-05 |
| ATA1041972A (de) | 1975-03-15 |
| DE2161344C3 (de) | 1986-10-02 |
| DK143201B (da) | 1981-07-20 |
| NL178014C (nl) | 1986-01-02 |
| NL7216628A (es) | 1973-06-13 |
| BE792484A (fr) | 1973-06-08 |
| AT326817B (de) | 1975-12-29 |
| DE2161344B2 (de) | 1980-05-08 |
| AU473209B2 (en) | 1976-06-17 |
| JPS5924137B2 (ja) | 1984-06-07 |
| CA988848A (en) | 1976-05-11 |
| CH577558A5 (es) | 1976-07-15 |
| IE36995B1 (en) | 1977-04-13 |
| DK143201C (da) | 1981-12-14 |
| PH12597A (en) | 1979-06-27 |
| DE2161344A1 (de) | 1973-06-20 |
| SU439956A3 (ru) | 1974-08-15 |
| FR2162637B1 (es) | 1976-07-02 |
| CS189587B2 (en) | 1979-04-30 |
| HU167086B (es) | 1975-08-28 |
| AU4992072A (en) | 1974-06-13 |
| JPS6011013B2 (ja) | 1985-03-22 |
| SE8400283D0 (sv) | 1984-01-20 |
| FR2162637A1 (es) | 1973-07-20 |
| NL178014B (nl) | 1985-08-01 |
| BG21417A3 (bg) | 1976-05-20 |
| AR204075A1 (es) | 1975-11-20 |
| SE8400283L (sv) | 1984-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT320149B (de) | Verfahren zur Herstellung eines attenuierten, modifizierten Pockenschutzimpfstoffes | |
| ES409464A1 (es) | Procedimiento para la produccion de cepas de virus. | |
| ATE4282T1 (de) | Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen. | |
| GB928807A (en) | Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture | |
| ES389845A1 (es) | Perfeccionamientos aportados a la construccion de hornos detubos anulares. | |
| FR2143588A1 (en) | Goose hepatitis live vaccine - for active immunization of water fowl | |
| ES392830A1 (es) | Procedimiento para la preparacion de una vacuna oral contrael tifus. | |
| ES452154A1 (es) | Procedimiento e instalacion de tratamiento de lodos. | |
| ES390603A1 (es) | Un procedimiento para la preparacion de un virus de varice-la vivo. | |
| ES226832A1 (es) | Un procedimiento para producir un producto de vacuna contra la poliomelitis | |
| ES331566A1 (es) | Procedimiento para la produccion de resinas furanicas. | |
| SU110698A1 (ru) | Способ автоклавной обработки силикатных и бетонных изделий | |
| ES259998A1 (es) | Procedimiento de preparaciën de copolimeros de poliesteres no saturados y de monëmetros no saturados copolimerizables | |
| GB219529A (en) | A new or improved process of producing a serum for protection against measles | |
| ES284278A1 (es) | Un método para seleccionar un virus | |
| ES279927A1 (es) | Procedimiento de preparaciën de una vacuna contra la fiebre aftosa | |
| ES202264A1 (es) | PROCEDIMIENTO PARA LA OBTENCIoN DEL DIHIDROPIRANO | |
| ES414799A1 (es) | Procedimiento para la preparacion de 1-aril-3-alcohiltiou- reas. | |
| ES330274A1 (es) | Procedimiento para preparar una vacuna contra las paperas. | |
| ES334812A1 (es) | Procedimiento para la preparacion de nuevos productos de polimerizacion de 8-hidroxiquinolinas. | |
| ES200200A3 (es) | PROCEDIMIENTO PARA LA OBTENCIoN DE PRODUCTOS RESULTANTES DE LA CONDENSACIoN DE 4-HIDROXICUMARINA, CON ALFA-BETA-CETONAS NO SATURADAS | |
| ES288641A1 (es) | Un método para producir un reactivo inmunológico | |
| ES7968U (es) | Lamas fabricadas con madera curvada | |
| ES254370A3 (es) | Procedimiento de preparaciën de un producto transparente e incoloro, apropiado para recubrir superficies | |
| ES333420A3 (es) | Un procedimiento para la fabricacion de placas sinteticas decorativas. |